8h
Zacks Investment Research on MSNUnited Community Banks (UCB) is a Top Dividend Stock Right Now: Should You Buy?Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your ...
The Grove AI Advisory Board brings together distinguished experts in global pharmaceutical strategy, AI innovation, and regulatory compliance. Advisory members will collaborate directly with Grove ...
Corebridge Financial Inc. purchased a new position in shares of United Community Banks, Inc. (NASDAQ:UCB – Free Report) ...
Can partnering ensure future success for pharma? UCB is very receptive to outside engagement. There is a real understanding within the company that being internally focussed and concentrating ...
UCB SA (OTCMKTS:UCBJF – Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 481,000 shares, a growth of 20.8% from the ...
Throughout the 1990s and early 2000s, UCB transformed from a hybrid pharma/chemical firm into a pure-play biopharmaceutical company by shedding its packaging, film, and chemical businesses.
Hosted on MSN16d
United Community Banks (UCB) Could Be a Great ChoiceUnited Community Banks (UCB) is headquartered in Greenville, and is in the Finance sector. The stock has seen a price change of -11.89% since the start of the year. The bank holding company is paying ...
UCB, a global biopharmaceutical company, today announced it will present 8 scientific abstracts, including 3 late-breaker oral presentations, highlighting key data from its innovative ...
Barclays analyst Charles Pitman CFA reiterated a Buy rating on UCB SA (0NZT – Research Report) today and set a price target of €240.00. The ...
1 Day UCB -0.98% DJIA -0.22% S&P Mid Cap 400 -0.71% Financial Services -0.92% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results